Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 41 | $381,516 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
18 Jun 2024 17:00 | ADAP | Adaptimmune Therapeutics PLC | PICCINA CINTIA | Chief Commercial Officer | 18 Jun 2024 | Sale | 24,531 | 0.93 | 22,814 | D |
17 Jan 2024 17:31 | ADAP | Adaptimmune Therapeutics PLC | RAWCLIFFE ADRIAN | Chief Executive Officer | 16 Jan 2024 | Sale | 9,304 | 0.79 | 7,350 | D |
17 Jan 2024 17:31 | ADAP | Adaptimmune Therapeutics PLC | RAWCLIFFE ADRIAN | Chief Executive Officer | 17 Jan 2024 | Sale | 30,080 | 0.673 | 20,244 | D |
17 Jan 2024 17:31 | ADAP | Adaptimmune Therapeutics PLC | NORRY ELLIOT | Chief Medical Officer | 17 Jan 2024 | Sale | 12,967 | 0.673 | 8,727 | D |
17 Jan 2024 17:31 | ADAP | Adaptimmune Therapeutics PLC | NORRY ELLIOT | Chief Medical Officer | 17 Jan 2024 | Sale | 5,309 | 0.673 | 3,573 | D |
17 Jan 2024 17:31 | ADAP | Adaptimmune Therapeutics PLC | NORRY ELLIOT | Chief Medical Officer | 16 Jan 2024 | Sale | 2,287 | 0.79 | 1,807 | D |
17 Jan 2024 17:30 | ADAP | Adaptimmune Therapeutics PLC | LUNGER JOHN | Chief Patient Supply Officer | 17 Jan 2024 | Sale | 12,805 | 0.673 | 8,618 | D |
17 Jan 2024 17:30 | ADAP | Adaptimmune Therapeutics PLC | LUNGER JOHN | Chief Patient Supply Officer | 16 Jan 2024 | Sale | 4,681 | 0.79 | 3,698 | D |
17 Jan 2024 17:30 | ADAP | Adaptimmune Therapeutics PLC | LUNGER JOHN | Chief Patient Supply Officer | 17 Jan 2024 | Sale | 5,309 | 0.673 | 3,573 | D |
17 Jan 2024 17:30 | ADAP | Adaptimmune Therapeutics PLC | BERTRAND WILLIAM C JR | Chief Operating Officer | 17 Jan 2024 | Sale | 13,599 | 0.673 | 9,152 | D |
17 Jan 2024 17:30 | ADAP | Adaptimmune Therapeutics PLC | BERTRAND WILLIAM C JR | Chief Operating Officer | 17 Jan 2024 | Sale | 5,309 | 0.673 | 3,573 | D |
17 Jan 2024 17:30 | ADAP | Adaptimmune Therapeutics PLC | BERTRAND WILLIAM C JR | Chief Operating Officer | 16 Jan 2024 | Sale | 4,681 | 0.79 | 3,698 | D |
12 Jan 2024 17:00 | ADAP | Adaptimmune Therapeutics PLC | NORRY ELLIOT | Chief Medical Officer | 12 Jan 2024 | Sale | 7,799 | 0.8541 | 6,661 | D |
12 Jan 2024 17:00 | ADAP | Adaptimmune Therapeutics PLC | NORRY ELLIOT | Chief Medical Officer | 11 Jan 2024 | Sale | 4,009 | 0.8367 | 3,354 | D |
12 Jan 2024 17:00 | ADAP | Adaptimmune Therapeutics PLC | BERTRAND WILLIAM C JR | Chief Operating Officer | 12 Jan 2024 | Sale | 5,220 | 0.8541 | 4,458 | D |
12 Jan 2024 17:00 | ADAP | Adaptimmune Therapeutics PLC | BERTRAND WILLIAM C JR | Chief Operating Officer | 11 Jan 2024 | Sale | 4,009 | 0.8367 | 3,354 | D |
12 Jan 2024 17:00 | ADAP | Adaptimmune Therapeutics PLC | RAWCLIFFE ADRIAN | Chief Executive Officer | 12 Jan 2024 | Sale | 17,257 | 0.8541 | 14,739 | D |
12 Jan 2024 17:00 | ADAP | Adaptimmune Therapeutics PLC | RAWCLIFFE ADRIAN | Chief Executive Officer | 11 Jan 2024 | Sale | 11,945 | 0.8367 | 9,994 | D |
12 Jan 2024 17:00 | ADAP | Adaptimmune Therapeutics PLC | LUNGER JOHN | Chief Patient Supply Officer | 11 Jan 2024 | Sale | 4,009 | 0.8367 | 3,354 | D |
12 Jan 2024 17:00 | ADAP | Adaptimmune Therapeutics PLC | LUNGER JOHN | Chief Patient Supply Officer | 12 Jan 2024 | Sale | 5,220 | 0.8541 | 4,458 | D |
01 Sep 2023 19:00 | ADAP | Adaptimmune Therapeutics PLC | RAWCLIFFE ADRIAN | Chief Executive Officer | 01 Sep 2023 | Sale | 2,403 | 0.78 | 1,874 | D |
01 Aug 2023 17:00 | ADAP | Adaptimmune Therapeutics PLC | LUNGER JOHN | Chief Patient Supply Officer | 01 Aug 2023 | Sale | 3,096 | 0.9056 | 2,804 | D |
10 Jul 2023 17:01 | ADAP | Adaptimmune Therapeutics PLC | MENZEL GARRY E | Director | 10 Jul 2023 | Sale | 47,702 | 0.9108 | 43,447 | D |
27 Jun 2023 21:15 | ADAP | Adaptimmune Therapeutics PLC | RAWCLIFFE ADRIAN | Chief Executive Officer | 27 Jun 2023 | Sale | 2,333 | 0.92 | 2,146 | D |
31 Jan 2023 21:02 | ADAP | Adaptimmune Therapeutics PLC | PICCINA CINTIA | Chief Commercial Officer | 31 Jan 2023 | Sale | 11,890 | 1.8696 | 22,230 | D |
17 Jan 2023 21:17 | ADAP | Adaptimmune Therapeutics PLC | LUNGER JOHN | Chief Patient Supply Officer | 17 Jan 2023 | Sale | 4,440 | 1.858 | 8,250 | D |
17 Jan 2023 21:17 | ADAP | Adaptimmune Therapeutics PLC | BERTRAND WILLIAM C JR | Chief Operating Officer | 17 Jan 2023 | Sale | 4,440 | 1.858 | 8,250 | D |
17 Jan 2023 21:16 | ADAP | Adaptimmune Therapeutics PLC | NORRY ELLIOT | Chief Medical Officer | 17 Jan 2023 | Sale | 2,159 | 1.858 | 4,011 | D |
17 Jan 2023 21:15 | ADAP | Adaptimmune Therapeutics PLC | RAWCLIFFE ADRIAN | Chief Executive Officer | 17 Jan 2023 | Sale | 10,057 | 1.858 | 18,686 | D |
12 Jan 2023 21:03 | ADAP | Adaptimmune Therapeutics PLC | BERTRAND WILLIAM C JR | Chief Operating Officer | 12 Jan 2023 | Sale | 4,973 | 1.706 | 8,484 | D |
12 Jan 2023 21:03 | ADAP | Adaptimmune Therapeutics PLC | BERTRAND WILLIAM C JR | Chief Operating Officer | 11 Jan 2023 | Sale | 3,843 | 1.7468 | 6,713 | D |
12 Jan 2023 21:02 | ADAP | Adaptimmune Therapeutics PLC | LUNGER JOHN | Chief Patient Supply Officer | 12 Jan 2023 | Sale | 4,973 | 1.706 | 8,484 | D |
12 Jan 2023 21:02 | ADAP | Adaptimmune Therapeutics PLC | LUNGER JOHN | Chief Patient Supply Officer | 11 Jan 2023 | Sale | 3,843 | 1.7468 | 6,713 | D |
12 Jan 2023 21:01 | ADAP | Adaptimmune Therapeutics PLC | NORRY ELLIOT | Chief Medical Officer | 12 Jan 2023 | Sale | 7,449 | 1.706 | 12,708 | D |
12 Jan 2023 21:01 | ADAP | Adaptimmune Therapeutics PLC | NORRY ELLIOT | Chief Medical Officer | 11 Jan 2023 | Sale | 3,843 | 1.7468 | 6,713 | D |
12 Jan 2023 21:00 | ADAP | Adaptimmune Therapeutics PLC | RAWCLIFFE ADRIAN | Chief Executive Officer | 12 Jan 2023 | Sale | 18,763 | 1.706 | 32,010 | D |
12 Jan 2023 21:00 | ADAP | Adaptimmune Therapeutics PLC | RAWCLIFFE ADRIAN | Chief Executive Officer | 11 Jan 2023 | Sale | 13,042 | 1.7468 | 22,782 | D |
04 Jan 2023 21:02 | ADAP | Adaptimmune Therapeutics PLC | BERTRAND WILLIAM C JR | Chief Operating Officer | 04 Jan 2023 | Sale | 3,584 | 1.694 | 6,071 | D |
04 Jan 2023 21:01 | ADAP | Adaptimmune Therapeutics PLC | LUNGER JOHN | Chief Patient Supply Officer | 04 Jan 2023 | Sale | 1,100 | 1.694 | 1,863 | D |
04 Jan 2023 21:01 | ADAP | Adaptimmune Therapeutics PLC | NORRY ELLIOT | Chief Medical Officer | 04 Jan 2023 | Sale | 876 | 1.694 | 1,484 | D |
04 Jan 2023 21:00 | ADAP | Adaptimmune Therapeutics PLC | RAWCLIFFE ADRIAN | Chief Executive Officer | 04 Jan 2023 | Sale | 5,073 | 1.694 | 8,594 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)